Heads of Schools
Prof. Michal Chowers, MD, heads the 4-Year Program of the School of Medicine. She is an Associate Clinical Professor at the School of Medicine and is the head of the Infectious Diseases Unit and the AIDS Center at the Meir Medical Center. She obtained her medical degree at Ben-Gurion University of the Negev, and her MPH at Tel Aviv University. Her infectious diseases specialty was done at the University of California San Diego, with basic research on HIV. Her current research focuses on the connection between antibiotic use and bacterial resistance in patients and their surroundings
Prof. Yariv Gerber, PhD, heads the School of Public Health and holds the Lilian & Marcel Pollak Chair in Biological Anthropology. He completed his direct track PhD at Tel Aviv University. He then continued his training in the Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, in cardiovascular disease epidemiology. He is Director of the Stanley Steyer Institute for Cancer Epidemiology and Research and an Adjunct Professor of Epidemiology at Mayo Clinic College of Medicine. Prof. Gerber studies risk factors for and time trends in various vascular diseases across different populations and settings, with the goal of improving public health and training future leaders in epidemiologic research. The ultimate goal of Gerber’s work is to reduce the massive burden of vascular disease through advancing the scientific basis for appropriate public health interventions.
Prof. Navah Ratzon, PhD, is Head of the School of Health Professions and is a member of the Department of Occupational Therapy. Among her other achievements, Ratzon chaired the Council for the Advancement of Women in Science and Technology at the Ministry of Science and Technology from 2016-2020. She is a member of the Advisory Council to the Minister of Health on the subject of rehabilitation and of the Advisory Committee to the Minister of Health and the Minister of Labor and Welfare on the subject of employee health. Prof. Ratzon is a social activist, engaged in developing community intervention programs and research among communities in need, such as children of immigrants from Ethiopia, children of foreign workers, and students with disabilities. Ratzon's research areas focus on ergonomics, vocational rehabilitation, and driving rehabilitation. She examines ways to assess driving ability and interventions to reduce the driving risks in professional drivers, adolescents with ADHD, people with schizophrenia, and people after a stroke.
Dr. Noa Eliakim Raz, MD, is head of the 6-Year Program of the School of Medicine and is a Senior Lecturer at the School of Medicine. She is the Head of Medicine E and a senior physician at the Infectious Disease Unit at the Rabin Medical Center. She obtained her medical degree from the School of Medicine at the Hebrew University. Her research focuses on infectious diseases and epidemiology, especially multi-drug resistant infections and treatment options in these infections, infections in immunosuppressed patients and older adults, clostridioides difficile infection and COVID-19.
Prof. Shlomo Matalon, DMD, is head of the School of Dental Medicine, and a member of the Department of Oral Rehabilitation. Among other achievements Prof. Matalon is a member of the Scientific Council of the Israeli Dental Association. Prof. Matalon is a co-founder of the International Association of Adhesive Dentistry, a board member of the Pan European Division of the International Association for Dental Research, a member of the Israeli Society of Prosthodontics, the American Academy of Operative Dentistry, and the American Dental Association. Prof. Matalon chairs the Quality Control Unit at ‘Clalit Smile’, the largest dental provider in Israel. Matalon’s research areas focus on antibacterial properties of dental materials and caries preventive particles.
Prof. Wolf completed his B. Med. Sc. and M.D. studies at the Faculty of Health Science, Ben Gurion University of the Negev and specialized in internal medicine and medical oncology at the Sheba Medical Center. He completed his MA at the Sackler Faculty of Medicine, Tel Aviv University and did a postdoctoral fellowship at the Division of Hematology Oncology, Cedar-Sinai Medical Center, UCLA School of Medicine under the supervision of Prof. HP Koeffler. He is the head of the School of Medicine. Prof. Wolf was former head of the Oncology Department at Sheba Medical Center and since 2016 heads the Oncology Division and the Oncology Research Lab at Tel Aviv Medical Center. Prof. Wolf is the head of the National Council for the Prevention and Treatment of Malignant Diseases and of the Tel Aviv University School of Medicine. He served as the Head of the Board Examination Committee in Oncology and is a member of the Board of the Israeli Cancer Association. His research focuses on endocrine aspects of cancer. His team discovered the tumor suppressor activities of the hormone klotho and was among the first to identify novel mutations of the estrogen receptor, which confer resistance to hormonal therapies. Current projects in the lab focus on the role of genomic alterations in determining tropism of metastases. He published over 120 peer-reviewed articles and won prestigious grants and awards, including ISF, BSF, ICA, Rappaport prize and the Hirchberg Foundation award.
Prof. Ronit Sagi-Eisenberg, PhD, holds the Herczeg Memorial Chair of Argentine Friends on Allergy and Related Diseases and is head of the Graduate School for Advanced Degrees. She is a full professor at the Department of Cell and Developmental Biology. She completed her PhD at Tel Aviv University and trained at the Weizmann Institute of Science and at the National Institutes of Health in the US. Prof. Sagi-Eisenberg’s research combines functional genomics analyses with high resolution microscopy to delineate the secretory response and identify the protein networks that control this process. Central proteins are marked as targets for the development of novel therapeutic means aimed at targeting the pathological activity of mast cells during disease. Central proteins are marked as targets for the development of novel therapeutic means aimed at targeting the pathological activity of mast cells during disease. More information at: https://rselab.wixsite.com/mysite
Prof. Ron Maymon, MD, MA (Education & Curriculum Development), heads the Academic Center for Continuing Medical Education, is Vice Dean for Education at the Shamir Medical Center, Chairman of the Department of OB/Gyn, Shamir Medical Center and Chairman of the Israeli Society of Obstetrics & Gynecology. Among other activities, Prof. Maymon is engaged for many years in medical education for undergraduate, post graduate, residents and overseas medical students. He is a member and chairs many national and international professional committees. Prof. Maymon works closely with officials from the Israeli Medical Association (IMA) and the Ministry of Health in coordinating between the training of medical students, interns and residents, integrating all professionals and facing the challenges of Israeli medicine for the next years.
